Description

Link to Reference

https://www.researchgate.net/publication/340547756_TaibUVID_for_Minimizing_COVID-19_Fatalities_and_Morbidity_An_Evidence-based_Approach_for_Better_Outcomes_A_Treatment_Protocol

Download PDF

The Evidence-Based Taib UVID Nutritional Treatment
for Minimizing COVID-19 Fatalities and Morbidity and
eradicating COVID-19 pandemic: A novel Approach for
Better Outcomes (A Treatment Protocol)
Salah Mohamed El Sayed1,2,3,*, Hamdi H. Almaramhy4
, Yasmeen Talal Aljehani5
, Ahmed M. Okashah6
,
Mariam E. El-Anzi7
, Mansour Barakah AlHarbi8
, Rehab El-Tahlawi9,10, Manal Mohamed Helmy Nabo11,
Moutasem Salih Aboonq12, Osama Hamouda3
, Osama Alhadramy13
1
Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University,
Al-Madinah Al-Munawwarah, Saudi Arabia 2
Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Egypt 3
Integrative Medicine and Prophetic Medicine Course and Research, Taibah Faculty of Medicine, Taibah University,
Al-Madinah Al-Munawwarah, Saudi Arabia 4
Department of surgery, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia 5
Family medicine programme & Ministry of Health Affairs & Sayed Al-Shuhada Primary Health Care Center,
Al-Madinah Al-Munawwarah, Saudi Arabia 6
Academic Affairs Director And Consultant Clinical Immunologist, Al-Madinah Directorate of Health, Al-Madinah Al-Munawwarah,
Ministry of Health, Saudi Arabia 7
Diabetic Center in King Fahd Hospital & Said Alshohada Primary Health Care Center, Al-Madinah Al-Munawwarah, Saudi Arabia 8
Head of training and academic affairs and Designated Institutional Official (DIO), King Fahad Hospital, Al-Madinah and Leader of
Training and Academic Affairs Taskforce, Al-Madinah Al-Munawwarah, Saudi Arabia 9
Department of Microbiology, College of Medicine, Taibah University, Saudi Arabia
10Department of Microbiology, Faculty of Medicine, Zagazig University, Egypt 11Division of Pediatric Cardiology, Pediatrics Department, Maternity and children hospital, Hail, Saudi Arabia 12Department of Medical Physiology, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia 13Division of Cardiology, Department of Medicine, Taibah College of Medicine, Taibah University,
Al-Madinah Al-Munawwarah, Saudi Arabia
*Corresponding author: salahfazara@yahoo.com
Received February 28, 2020; Revised March 29, 2020; Accepted April 06, 2020
Abstract With the continuously expanding terrible pandemic of COVID-19 infection, globally increasing
numbers of COVID-19 patients and contacts progressively jump to heavy burdens beyond capabilities. Developing
and poor countries may face humanity disasters in the next few days unless urgent measures are rapidly performed.
Standard anti-COVID-19 treatment should inhibit COVID-19 replication, repair virus-induced tissue damage and
enhance patients’ immunity. Unfortunately, such criteria are still lacking in current treatments resulting in relatively
high viral infectivity, morbidity and mortality. Based on previous prophetic medicine research experience and the
modern literature, we introduce TaibUVID therapy as a novel evidence-based medicinal nutritional treatment for
eradicating COVID-19 pandemic. TaibUVID stands for Taibah University anti-COVID-19 treatment as a novel
evidence-based approach (using natural products) for treating COVID-19 patients. A single TaibUVID dose includes:
1 small spoonful (tea spoonful) of nigella sativa oil (or 2 gram nigella sativa seeds) mixed with 1 gram of grinded
anthemis hyalina mixed with 1 large spoonful of natural honey. This mixture is to be chewed in the mouth and
swallowed orally for both COVID-19 contacts and patients. We adjusted dosing regimen and period of treatment
into three clinical levels including contacts or prophylaxis, mild cases and severe case (with pneumonia and
ventilated patients). We also introduce novel nigella sativa oil (or nigella sativa decoction) nebulization for local
treatment of pneumonia or bronchopneumonia that is faced in severe COVID-19 cases. Such nebulization exerts
pulmonary tissue protection and antiviral effects particularly for ventilated patients. The wonderful report by Ulasli
et al. (Ulasli et al. Mol Biol Rep. 2014; 41: 1703-11) deserves a lot of interest where nigella sativa and Anthemis
hyalina (chamomile) were confirmed to inhibit corona virus replication maximally. In addition, nigella sativa
enhances immunity, exerts tissue protective effects and effectively treats co-morbidities. Oral honey exerts potent
antiviral effects, enhances immunity and exerts tissue protective effects. TaibUVID Plus dose includes regular
TaibUVID dose plus nigella sativa decoction nebulization ± (if possible Clove oil nebulization/ anthemis hyalina
decoction nebulization). Clove oil nebulization is beneficial for difficult berating in some COVID-19 cases as clove
is confirmed to exert potent antiviral effects. Our suggested TaibUVID and TaibUVID Plus are promising
American Journal of Public Health Research 55
evidence-based approach to rescue lives, decrease fatalities and put a rapid end to COVID-19 pandemic. In prophetic
medicine, Prophet Muhammad peace be upon him recommended treatment using both nigella sativa and oral honey
saying: ” In the black cumin (nigella sativa), there is a cure for every disease except death” and said also: “Cure
is in three: in shartat mihjam, gulp of honey (oral honey), and cauterization. I do not recommend my nation
to cauterize”.
Keywords: COVID-19, TaibUVID, nigella sativa, anthemis hyalina, oral honey and citrus sinensis
Cite This Article: Salah Mohamed El Sayed, Hamdi H. Almaramhy, Yasmeen Talal Aljehani, Ahmed M.
Okashah, Mariam E. El-Anzi, Mansour Barakah AlHarbi, Rehab El-Tahlawi, Manal Mohamed Helmy Nabo,
Moutasem Salih Aboonq, Osama Hamouda, and Osama Alhadramy, “The Evidence-Based TaibUVID Nutritional
Treatment for Minimizing COVID-19 Fatalities and Morbidity and eradicating COVID-19 pandemic: A novel
Approach for Better Outcomes (A Treatment Protocol).” American Journal of Public Health Research, vol. 8, no.
2 (2020): 54-60. doi: 10.12691/ajphr-8-2-3.

TAIB -UVID HONEY PLUS

All mixed up for you

TAIB -UVID HONEY PLUS